company insight

Pharma Support Services Ltd  - your regulatory and pharmaco vigilance provider in Eastern Europe

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes -

Achieving compliance with local requirements can be a tough deal and an unexpected challenge sometimes

Hence you need a partner you can trust

Given the diversity of the Eastern European region and the fact that the languages spoken are very different from one another (as both Cyrillic and Latin alphabets are used in the region dependent on the country) launching your products can be a challenge. It needs to be matched with a local expertise in regulatory affairs, pharmacovigilance and pricing - all of which are essentials for speedy access to Eastern European markets. Whether you are only exploring possibilities to expand or already have presence in Eastern Europe we can adapt our services to be of help to your business.

As a first prerequisite we ensure you receive a well-grounded legal advice and country-specific background. Based in Sofia, Bulgaria and having reliable partners all over Eastern Europe, we can find the right partner for you should you be looking for a GMP, GDP compliant warehouse or support with medical devices and medicinal products registration and their pricing and reimbursement possibilities. As the healthcare systems in many of the countries in the region are based on the so-called „external reference pricing system“ we can provide guidance on which countries are included in the reference basket and what strategy can be adopted to secure your product on the market.  

we can find the right partner for you should you be looking for a GMP

Worried about Brexit outcome?

Further down the line of establishing in your business in Eastern Europe we are happy to support you with transfer of marketing authorisations, finalization of national phases of your DCP/MRP applications as well as start a national authorisation procedure for your product, should you be interested in one market only. We have a broad expertise in registration and communication of all necessary requirements so that you can focus on marketing your products while we do the rest.

In addition to local pharmacovigilance point of contact as well as literature screening of non-indexed journals and publications we perform follow-up assessment of relevant articles/scientific extracts. Medical review of cases published in literature can help you identify important signals concerning the safety profile of your products. And a lot of locally issued journals are not indexed by Embase and Medline, so we can provide further assistance with these issues.

Share this article

Go to article: Home | Mapping the MindGo to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: EditorialGo to article: Biocorp Company InsightGo to article: BiocorpGo to article: ContentsGo to article: Fisher Clinical ServicesGo to article: Malvern Panalytical Company InsightGo to article: Malvern PanalyticalGo to article: NewsGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The Pharma Industry BriefingGo to article: Mattler ToledoGo to article: MedelpharmGo to article: HPV vaccines: a decade of progressGo to article: Nipro PharmaPackagingGo to article: PfanstiehlGo to article: Hereditary Alzheimer’s: could rare genes hold the clue to a cure?Go to article: SGSGo to article: Capsugel Company InsightGo to article: CapsugelGo to article: Could a unique brain fingerprint predict a drug’s effectiveness?Go to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: Genetic studies: a powerful tool for testing combination therapiesGo to article: Nelson Lab Company InsightGo to article: Nelson LabGo to article: Abiogen PharmaGo to article: The Express Scripts story; super-pharmacies and the US drug industryGo to article: B Medical SystemsGo to article: Daiichi JitsugyoGo to article: LaudaGo to article: Is a lack of female participants skewing heart disease trial results?Go to article: EcocoolGo to article: HOF SonderanlagenbauGo to article: DiverseyGo to article: Why the German Centre for Diabetes Research changed its approach to handling dataGo to article: Dow Europe GmbH Company InsightGo to article: Dow Europe GmbHGo to article: QualiMetriXGo to article: How digital innovation is helping to drive transformation in regulatory affairs Go to article: DryceGo to article: ILC Dover IncGo to article: Pall BiotechGo to article: EventsGo to article: Event: Pharmpack EuropeGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: Unither PharmaceuticalsGo to article: Next issueGo to article: ButterworthGo to article: myLiquitab